NT5E and pneumonitis: Thus, an anti-CD73 therapy could promote epithelial-induced pro-inflammatory signaling, enhanced vascular leakage and reduced pulmonary oedema clearance with a potential contribution to enhanced normal tissue damage and pneumonitis.